Literature DB >> 7561759

Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.

A L Glaser1, A A de Vries, E J Dubovi.   

Abstract

Three murine monoclonal antibodies (MAbs) that neutralize equine arteritis virus (EAV) infectivity were identified and characterized. The antibodies, 93B, 74D(B) and 38F, recognized the major envelope glycoprotein (GL) encoded by open reading frame (ORF) 5 in immunoblots and by immunoprecipitation. All three MAbs were used to compare the Bucyrus isolate of EAV and MAb neutralization-resistant (NR) escape mutants with the vaccine virus and 19 independent field isolates of EAV by virus neutralization. The different abilities of the MAbs to neutralize virus isolates indicated that they recognize non-identical epitopes. Susceptibility to virus neutralization could not be used to distinguish viruses from acutely and persistently infected horses. Comparison of the ORF 5 nucleotide and deduced amino acid sequence from NR and neutralization-sensitive virus isolates revealed amino acid sequence changes at positions 99 and 100 which correlate with the NR phenotype. Additional unique changes in the amino acid sequence of MAb NR viruses at positions 96 and 113 may also contribute to neutralization resistance. The sequence data further showed that the Bucyrus-derived viruses contain one N-glycosylation site, whereas the field isolates DL8 and DL11 possess two sites, both of which are used. Most of the non-conservative amino acid sequence changes were located within the second half of the N-terminal hydrophilic domain. Sequence changes within the first half of the N-terminal ectodomain, the predicted transmembrane domain and the C-terminal hydrophilic domain were mainly silent base substitutions or resulted in conservative amino acid substitutions, suggesting that these regions of the protein are functionally conserved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561759     DOI: 10.1099/0022-1317-76-9-2223

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences.

Authors:  G van Marle; J C Dobbe; A P Gultyaev; W Luytjes; W J Spaan; E J Snijder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus.

Authors:  J J Meulenberg; A P van Nieuwstadt; A van Essen-Zandbergen; J P Langeveld
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.

Authors:  E Weiland; S Bolz; F Weiland; W Herbst; M J Raamsman; P J Rottier; A A De Vries
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Comparison of nucleic and amino acid sequences and phylogenetic analysis of the Gs protein of various equine arteritis virus isolates.

Authors:  N Lepage; G St-Laurent; S Carman; D Archambault
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity.

Authors:  Eric J Snijder; Jessika C Dobbe; Willy J M Spaan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex.

Authors:  K W Pedersen; Y van der Meer; N Roos; E J Snijder
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Proteolytic processing of the open reading frame 1b-encoded part of arterivirus replicase is mediated by nsp4 serine protease and Is essential for virus replication.

Authors:  L C van Dinten; S Rensen; A E Gorbalenya; E J Snijder
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.

Authors:  Javier Castillo-Olivares; Roeland Wieringa; Tamás Bakonyi; Antoine A F de Vries; Nick J Davis-Poynter; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein.

Authors:  B Pirzadeh; C A Gagnon; S Dea
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

10.  Nucleotide sequence and genetic analysis of the leader region of Canadian, American and European equine arteritis virus isolates.

Authors:  A Kheyar; G St-Laurent; M Diouri; D Archambault
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.